Enhanced radioresponse of paclitaxel-sensitive and -resistant turnouts in vivo

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1299-1308

  Milross, C G ^a,b   Mason, K A ^a   Hunter, N R ^a   Terry, N H A ^a   Patel, N ^a   Harada, S ^a   Jibu, T ^a   Seong, J ^a   Milas, L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Apoptosis; Cell cycle; Mitosis; Oxygen; Paclitaxel; Radiation

Indexed keywords

CREMOPHOR; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE PHASE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MITOSIS; NEOPLASM TRANSPLANTATION; PACLITAXEL; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SKIN;

EID: 0030748489     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00107-X     Document Type: Article

References (38)

1. Milas L, Hunter NR, Kurdoglu B, et al. Kinetics of mitotic arrest and apoptosis in murine mammary ovarian tumors treated with taxol. Cancer Chemother Pharmacol 1995, 35, 297-303.
2. Milross CG, Peters LJ, Hunter NR, Mason KA, Milas L. Sequence-dependent antitumor activity of paclitaxel (Taxol) and cisplatin in vivo. Int J Cancer 1995, 62, 599-604.
3. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996, 88, 1308-1314.
4. Holmes FA, Walters RS, Theriault RL, et al. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991, 83, 1797-1805.
5. McGuire WP, Rowinsky EK, Rosenhein NB, et al. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989, 111, 273-279.
6. Schiff PB, Fant S, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277, 665-667.
7. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980, 77, 1561-1565.
8. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992, 52, 3495-3497.
9. Bhalla K, Ibrado AM, Tourknia E, et al. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993, 7, 563-568.
10. Gangemi RMR, Tiso M, Marchetti C, et al. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 1995, 36, 385-392.
11. Terry HA, Milross CG, Patel N, Mason KA, White RA, Milas L. The effect of paclitaxel on cell cycle kinetics of a murine mammary adenocarcinoma in vivo. Breast J 1997, 3, 99-105.
12. Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophys J 1963, 3, 11-33.
13. Sinclair WK, Morton RA. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster ovary cells. Radiat Res 1966, 29, 450-474.
14. Withers HR, Mason KA, Reid BO, Dubrovsky N, Barkley HT, Brown BW. Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. Cancer 1974, 34, 39-47.
15. Choy H, Rodriguez FF, Koester S, Hilsenbach S, Von Hoff DD. Investigation of taxol as a potential radiation sensitizer. Cancer 1993, 71, 3774-3778.
16. Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. In vitro studies of taxol as a potential radiation sensitizer. J Natl Cancer Inst 1994, 86, 441-446.
17. Steren A, Sevin BU, Perras J, et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993, 48, 252-258.
18. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995, 55, 3564-3568.
19. Milas L, Saito Y, Hunter NR, Milross CG, Mason KA. Therapeutic potential of paclitaxel radiation treatment of a murine ovarian carcinoma. Radiother Oncol 1996, 40, 163-170.
20. Legha SS, Ring S, Papadopoulos N, Raber M, Benjamin RS. A phase II trial of taxol in metastatic melanoma. Cancer 1990, 65, 2478-2481.
21. Gian V, Lynch J, McCarley D, Johnson T. Taxol in the treatment of recurrent or metastatic soft tissue or osteosarcomas. Proc Am Soc Clin Oncol 1995, 14, 516.
22. Roth BJ, Yeap BY, Wilding G, Kasimis B, Mcleod D, Loehrer PJ. Taxol in advanced, hormone refractory carcinoma of the prostate. Cancer 1993, 72, 2457-2460.
23. Thigpen T, Vance B, Khansur T. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Semin Oncol (5 Suppl 12) 1995, 22, 67-75.
24. Mason KA, Milas L, Peters LJ. Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int J Radiat Oncol Biol Phys 1995, 32, 1381-1389.
25. Milas L, Hunter N, Mason K, Withers HR. Immunologic resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 1974, 34, 61-71.
26. Suit H, Allam A, Allalunis-Turner J, et al. Is tumor cell radiation resistance correlated with metastatic ability. Cancer Res 1994, 54, 1736-1741.
27. Stephens LC, Ang KK, Schulteiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991, 127, 308-316.
28. 2 measurement in mice: effect of tumor type, site of implantation, and anesthesia. Radiat Oncol Invest 1996, 4, 108-114.
29. Carlton JC, Terry NHA, White RA. Measuring potential doubling times of murine tumors using flow cytometry. Cytometry 1991, 12, 645-650.
30. Ruifrok ACC, Mason KA, Hunter N, Thames HD. Changes in the radiation sensitivity of mouse skin during fractionated and prolonged treatments. Radiat Res 1994, 139, 334-343.
31. Gregoire V, Hunter N, Brock B, Milas L, Plunkett W, Hittelman W. Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation. Int J Radiat Oncol Biol Phys 1994, 30, 363-371.
32. Stone HB. Leg contracture in mice: An assay of normal tissue response. Int J Radiat Oncol Biol Phys 1984, 10, 1053-1061.
33. Withers HR, Peters LJ. Biologic aspects of radiation therapy. In Fletcher GH, ed. Textbook of Radiotherapy, 3rd edn. Lea & Febiger, Philadelphia, 1980.
34. 2. Acta Oncol 1997, 36, 183-189.
35. Saito Y, Milross CG, Hittelman MN, Li D, Jibu T, Peters LJ, Milas L. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys, in press.
36. Tishler RB, Lampus DM, Park S, Price BD. Microtubule-active drugs taxol, vinblastine, and micodazole increase the levels of transcriptionally active p53. Cancer Res 1995, 55, 6021-6025.
37. Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1995, 1, 506-526.
38. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996, 56, 1253-1255.